Merck October 1, 2021 9:33 am

Merck Says Pill, Molnupiravir, Cuts Rate of COVID Hospitalization in Half

Drugmaker Merck said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus.

Local

2:05

Whoopi Goldberg reveals who will inherit her fortune
2:48

Taylor Swift fans react to Jake Gyllenhaal and Sabrina Carpenter's ‘SNL' appearance
3:11

Ryan Gosling skips darker film roles because of Eva Mendes and daughters
1:59

TikTok's Maddy Baloy dead at 26: Gordon Ramsay and Tay Lautner pay tribute
0:45

Lakers fire head coach Darvin Ham
Exit mobile version